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Abstract  
Advance care planning (ACP) is increasingly implemented in oncology and beyond, but a definition of 
ACP and recommendations concerning its use are lacking. We conducted a formal consensus 
procedure to develop these. 109 experts (82 from Europe, 16 from North America, and 11 from 
ƵƐƚƌĂůŝĂ ?ƌĂƚĞĚWĚĞĨŝŶŝƚŝŽŶƐĂŶĚ ? ?ƌĞĐŽŵŵĞŶĚĂƚŝŽŶƐ ?dŚĞƉĂŶĞů ?ƐĂŐƌĞĞŵĞŶƚƉĞƌĚĞĨinition or 
recommendation was 68%-  ? ? ?A? ?WǁĂƐĚĞĨŝŶĞĚĂƐ “ĞŶĂďůŝŶŐŝŶĚŝǀŝĚƵĂůƐƚŽĚĞĨŝŶĞŐŽĂůƐĂŶĚ
preferences for future medical treatment and care, to discuss these goals and preferences with 
ĨĂŵŝůǇĂŶĚŚĞĂůƚŚĐĂƌĞƉƌŽǀŝĚĞƌƐ ?ĂŶĚƚŽƌĞĐŽƌĚĂŶĚƌĞǀŝĞǁƚŚĞƐĞƉƌĞĨĞƌĞŶĐĞƐŝĨĂƉƉƌŽƉƌŝĂƚĞ ? ?
ZĞĐŽŵŵĞŶĚĂƚŝŽŶƐŝŶĐůƵĚĞĂĚĂƉƚŝŶŐWƚŽŽŶĞ ?ƐƌĞĂĚŝŶĞƐƐ ?ƚĂƌŐĞƚŝŶŐŝƚƐĐŽŶƚĞŶƚĂƐŽŶĞ ?ƐŚĞĂůƚŚ
condition worsens, and trained non-physician facilitators to support the ACP process. We present a 
list of outcome measures to enable pooling and comparing ACP study results. Our set can provide 
guidance for clinical practice, ACP policy and research.   
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Introduction  
Advance care planning (ACP) enables individuals to make plans about their future healthcare. Robust 
evidence from systematic reviews shows that ACP increases completion of advance care directives 
and occurrence of discussions about future healthcare in clinical practice, and improves consistency 
of care with patients' goals among a variety of patient populations, including oncology.
1,2
 ACP can 
improve the quality of patient-clinician communication, reduce unwanted hospitalisations, increase 
the use of palliative care, and increase patient satisfaction and quality of life.
1,2
 Recent evidence 
suggests a broad support for ACP among cancer patients and their healthcare providers.
3
 Interest in 
ACP continues to grow, as indicated by a rising number of scientific publications, programmes, laws, 
and public awareness campaigns. At the same time, several challenges in ACP require greater 
consensus. 
 
First, the concept and content of ACP varies considerably. Originally, ACP was conceptualised as the 
mere completion of an advance care ĚŝƌĞĐƚŝǀĞƚŽďĞƵƐĞĚǁŚĞŶƚŚĞŝŶĚŝǀŝĚƵĂů ?ƐĐĂƉĂĐŝƚǇƚŽŝŶĚŝĐĂƚĞ
preferences had been lost. Recently, ACP has increasingly been considered as a complex process that 
ŝŶĐůƵĚĞƐƉĞƌƐŽŶĂůƌĞĨůĞĐƚŝŽŶŽŶŽŶĞ ?ƐǁŝƐŚĞƐ ?ƚŚe appointment of a healthcare representative, 
ĚŝƐĐƵƐƐŝŽŶƐǁŝƚŚĐůŝŶŝĐŝĂŶƐĂďŽƵƚŽŶĞ ?ƐǁŝƐŚĞƐ ?ĐŽŵƉůĞƚŝŽŶŽĨan advance care directive, and 
healthcare system changes. This has resulted in growing interest in ACP beyond geriatric 
populations, such as in oncology.
3
 Prior initiatives to define ACP have limited generalisability as they 
are mostly restricted to North America or the UK,
4-7
 or to specific patient groups or disciplines.
6,8
 
Secondly, there is a need for guidance regarding the timing of ACP. Introducing ACP too early may 
lead to reluctance to engage in ACP. However, engaging in ACP in the face of a crisis or shortly 
before dying may be too late.
9
 A third challenge in ACP is that differences in patients' preferences, 
knowledge, and health literacy may complicate healthcare professionals ? navigation of ACP.10 Lastly, 
there is an urgent need to determine the most relevant outcome measures for evaluating ACP. 
 
To date, there is no consensus regarding the definition of ACP, nor are there practice 
recommendations that are applicable to a variety of cultural settings and personal values. This 
hinders the development of ACP programmes and ƚŚĞĞǀĂůƵĂƚŝŽŶŽĨW ?ƐĞĨĨĞĐƚŝǀĞŶĞƐƐ. Therefore, 
we aimed to: (1) Develop a consensus definition of ACP; (2) Present recommendations for ACP that 
can be used by healthcare providers, policy makers and researchers across a broad spectrum of 
patient populations, disease categories, and cultures.  
 
Methods  
An international taskforce consisting of 15 recognised experts from eight countries (BE, CAN, DE, IRL, 
IT, NL, UK, USA) conducted a five-round Delphi study to build a systematic consensus on ACP. The 
European Association for Palliative Care (EAPC) Board commissioned this consensus project and 
invited JR and IK to chair the taskforce, based on their expertise in ACP and interdisciplinary and 
international comparative prior work. They invited to the taskforce well-known experts in ACP with 
the aim to comprise an international and interdisciplinary group, including experts from a range of 
regional areas, experts with clinical experience and those with research experience, experts from 
oncology, palliative care, geriatrics and ethics. These experts were identified either through their 
publication and citation track record or through contacts from the professional network of JR and IK 
or that of the EAPC Board. Rounds 1 and 5 used a qualitative approach, while Rounds 2, 3 and 4 
were structured. As defined by the standard Delphi process, the structured rounds were 
characterised by anonymity (protecting the Delphi results from the influences of group conformity), 
iteration (allowing for change of opinions), and controlled feedback (communicating the results of 
the previous round).
11,12
   
 
Round 1 
In June 2014, during a two-day meeting at the Netherlands Institute for Advanced Study in 
Wassenaar (the Netherlands), the taskforce established 2 draft definitions and 5 
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ACP: elements, roles and tasks, timing, policy and regulation, and evaluation. We opted to establish 
an extended definition to be used in, for instance, research and education of health care staff, and a 
brief definition for practical use. To address each domain in detail, working groups were set up 
which consisted of four to five taskforce members. Within each domain, recommendations were 
developed, based as much as possible on evidence derived from the literature and on expert 
opinion. We studied the literature (in 2014 and updated in 2016) in three ways. First, we conducted 
a meta-review.
13
 We searched PubMed for ƉƵďůŝĐĂƚŝŽŶƐǁŝƚŚƚŚĞƚĞƌŵ “ĂĚǀĂŶĐĞĐĂƌĞƉůĂŶŶŝŶŐ ?ĂŶĚ
included reviews and meta-analyses. The search was limited to title or abstract search fields. 
Reviews could include quantitative and qualitative studies. This resulted in 89 reviews and one meta-
analysis that we studied, including all the publications in the respective reference lists. The studies 
were used to support the recommendations. Second, we searched for existing guidelines of position 
papers, by searching PubMed for publications with the term  “ĂĚǀĂŶĐĞĐĂƌĞƉůĂŶŶŝŶŐ ?ĐŽŵďŝŶĞĚǁŝƚŚ
 “ŐƵŝĚĞůŝŶĞ ?Žƌ “ƉŽƐŝƚŝŽŶƉĂƉĞƌ ? ?We performed a comparable search in Google, and additionally 
checked all identified reviews (including their references) for references to guidelines or position 
papers. This yielded five clinical practice guidelines.
5-8,14 
Third, each working group conducted a 
specific PubMed literature search for each domain (definition, core elements, roles and tasks, 
ƚŝŵŝŶŐ ?ƉŽůŝĐǇĂŶĚƌĞŐƵůĂƚŝŽŶ ?ĂŶĚĞǀĂůƵĂƚŝŽŶ ? ?ĐŽŵďŝŶŝŶŐƚŚĞƚĞƌŵ “ĂĚǀĂŶĐĞĐĂƌĞƉůĂŶŶŝŶŐ ?ǁŝƚŚ
relevant keywords for their section. For instance, the definitions formulated were based on 25 
definitions derived from the literature, and we were able to leverage the work on the definition of 
ACP and outcomes ratings as conducted predominantly in North America.
4
 The draft definitions and 
recommendations were discussed and improved eight times within the taskforce (by email and in 
face-to-face meetings and tele-meetings) over the course of one year. This process resulted in 
extended and brief definitions of ACP, along with 37 draft recommendations. 
 
Round 2   
In September 2015, the extended and brief definition and the draft recommendations were 
presented to an expert panel through an online questionnaire using LimeSurvey software 
(https://www.limesurvey.org/). In a separate Word document, we provided the panellists with the 
definitions and recommendations including the supporting literature references to allow the 
panellists to study these as well. An overview of this literature, including the update in 2016, can be 
found in the table. Potential panel experts (including patient representatives) were identified 
through their publication and citation track record or through the professional networks of the 
members of the taskforce and that of the EAPC Board. In the selection, we aimed for an 
international and interdisciplinary group of ACP experts. The invited panellists were experts in ACP 
research, practice, and policy, with backgrounds in medicine, nursing, palliative care, psychology, 
ethics, law, and policy. Panellists also included nine patient representatives who were trained 
ŵĞŵďĞƌƐŽĨƚŚĞ “ǆƉĞƌƚsŽŝĐĞƐ'ƌŽƵƉ ?ŽĨDĂƌŝĞƵƌŝĞĂŶĚǁŚŽŚĂĚĨŝƌƐƚ-hand experience with end-
of-life care as a relative or friend, for instance, a 19-year old student who was closely involved in the 
provision of care for three close family members.  To establish a multinational perspective, we 
invited experts from multiple countries (US, Canada, Australia, and different European regions). We 
invited 144 experts, of whom 124 agreed to participate (86%) and received the online questionnaire. 
Of these, 109 completed the questionnaire (response: 109/144=76%). The most common reason for 
ĚĞĐůŝŶŝŶŐƉĂƌƚŝĐŝƉĂƚŝŽŶǁĂƐ “ůĂĐŬŽĨƚŝŵĞ ? ?The Appendix presents the characteristics of the expert 
panel. They originate from 14 countries. Of the 124 panellists, 83 indicated to work in clinical 
practice, mostly as a physician or a nurse. Of the 51 physicians, 34 were in the field of oncology or 
palliative medicine. The number of years that panellists worked in ACP was not asked.  
 
For the definitions and each of the recommendations, panellists were asked to indicate the extent of 
their agreement on a 7-point Likert scale (answering categories: 1=strongly agree; 2=agree; 3=agree 
somewhat; 4=undecided; 5=disagree somewhat; 6=disagree; 7=strongly disagree). In addition, they 
could provide their feedback on the definitions and on each recommendation in text boxes, and 
ƐƉĞĐŝĨǇǁŚĞƚŚĞƌƚŚĞƌĞǁĞƌĞŝŵƉŽƌƚĂŶƚŽŵŝƐƐŝŽŶƐ ?dŚĞƉĂŶĞůůŝƐƚƐ ?ƌĞƐƉŽŶƐĞƐǁĞƌĞƵsed to calculate 
levels of agreement and consensus.
15, 16
 Agreement is indicated in two ways: by the percentage of 
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respondents either agreeing or strongly agreeing with a definition or recommendation, and by the 
median score, which represents the 50th percentile value of opinions. A smaller median indicates 
more agreement; a median of 1 indicated very strong agreement, and a median of 2 indicated strong 
agreement.
17
 Consensus was calculated by the interquartile range (IQR), which represents the 
distance between the 25th and the 75th percentile value of ratings. A smaller IQR indicates more 
consensus; an IQR of 0 or 1 indicated very strong consensus, and an IQR of 2 indicated strong 
consensus.
18
 Open comments were all analysed line by line by the respective working group as well 
as by JR and IK, and recommendations were revised if appropriate. Recommendations that received 
very strong agreement and very strong consensus were accepted (or underwent small textual edits 
only). All other recommendations were adapted with respect to their content, wording, and/or 
ordering, or were eliminated (to reduce redundancy). Proposals for adaptations were discussed 
several times within the working groups and within the taskforce.  
 
Round 3  
To maintain conformity between rounds, only those panellists who responded in Round 2 were 
asked to respond to revised recommendations in Round 3. In the third round (May 2016), Round 2 
respondents (n=109) were provided the original set of two definitions and recommendations 
including median and IQR scores, as well as the revised set. Again, panellists could indicate the 
extent of their agreement on a 7-point Likert scale and provide their feedback. If recommendations 
had received very strong agreement and very strong consensus in the second round, experts were 
presented a choice between selecting the default option (that is, the median score of that 
recommendation in the previous round) or, alternatively, to rate the recommendation again. Of the 
109 panellists from Round 2, 103 responded in Round 3 (94%).  
 
Round 4  
Recommendations that received very strong agreement (a median of 1) and very strong consensus 
(an IQR of 0 or 1) were accepted (or underwent small textual edits only). The other 
recommendations were adapted by JR and IK, based on ƚŚĞƉĂŶĞůůŝƐƚƐ ?ĐŽŵŵĞŶƚƐ ?dŚĞƌĞǀŝƐĞĚƐĞƚ
was sent to the 15 members of the taskforce in August 2016, who each independently indicated 
whether they agreed with the suggested changes per adapted recommendation (yes/no), and if not, 
whether they could suggest further improvements.  
 
Round 5 
The set was adapted according to the final feedback of the taskforce. The full set was then sent to 
the EAPC Board of Directors.  
 
Role of study sponsors 
The study sponsor had no role in the study design, in the collection, analysis, and interpretation of 
data, in the writing of the report or in the decision to submit the paper for publication. The 
corresponding author (JACR) confirms that she had full access to all data in the study and had final 
responsibility for the decision to submit for publication.  
 
Results  
Summary of the rounds  
The flowchart in Figure 1 presents an overview of the five rounds. In Round 2, the extended 
definition was rated with a median of 2 and an IQR of 1, and the brief definition with a median of 2 
and an IQR of 2. Furthermore, 28 of the 37 recommendations (78%) received very strong agreement 
and very strong consensus (a median of 1 and an IQR of 0 or 1). In Round 3, the extended definition 
was rated with a median of 2 and an IQR of 1, and the brief definition with a median of 2 and an IQR 
of 1. For 36 of the 44 recommendations (78%), agreement and consensus were very strong. In 
Round 4, tǁĞůǀĞŽĨƚŚĞƚĂƐŬĨŽƌĐĞ ?Ɛ ? ?ŵĞŵďĞƌƐƌĂƚĞĚƚŚĞƌĞŵĂŝŶŝŶŐƐĞƚŽĨĞŝŐŚƚ recommendations. 
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Four recommendations received agreement by all members, the other four by 7 to 11 of the 12 
members. The provided feedback mainly concerned small textual changes. These changes were 
made eventually resulting in a final set that reached consensus of the full taskforce. The full final set 
comprised of a brief definition, an extended definition, and 41 recommendations (including 14 ACP 
outcome measures). These are listed in the Table. The full final set was reviewed by the EAPC board 
members, who were unanimous in their support and had no suggested revisions. 
 
Definition  
The box shows the extended and brief consensus definitions of ACP.  
 
Box: Consensus definitions of advance care planning  
 
The brief consensus definition contains all the key elements of the extended consensus definition. A 
central element of the definitions is that ACP is considered to be a process which includes identifying 
values and defining goals and preferences for future medical treatment and care, and discussing 
these with family and healthcare providers. It may include the documentation of preferences or the 
appointment of a proxy decision maker. These preferences should be regularly reviewed. Other key 
points are that the scope of ACP is broader than the physical domain alone (and may include 
concerns across the psychological, social, and spiritual domains) and that ACP is not limited to 
specific patient groups (yet should concern individuals with decisional capacity). Both final 
definitions were rated with a median of 2 and an IQR of 1 in Round 3. Overall, 88% of panellists 
(versus 83% in Round 2) indicated that they agreed or strongly agreed with the extended definition, 
and 89% (versus 65% in Round 2) with the brief definition. In total, the panellists provided 97 
comments with suggestions for improvement regarding the extended definition, and 88 regarding 
the brief definition. Adaptations of the extended and brief definitions predominantly concerned the 
addition that individuals must have decisional capacity to engage in ACP, the inclusion of the social 
domain, and the importance of reviewing preferences.   
 
Recommendations 
The table presents the 41 consensus recommendations for ACP, along with their respective 
agreement and median scores, IQRs, and the number of comments provided by the panellists. Of the 
41 recommendations, 36 (88%) received very strong consensus and very strong agreement, three 
(7%) strong agreement and very strong consensus, and two (5%) strong agreement and strong 
consensus.   
 
The recommendations concern five domains of ACP: elements (12 recommendations), roles and 
tasks (six recommendations), timing (three recommendations), policy and regulation (five 
recommendations), and evaluation (15 recommendations).  
 
Recommendations that received very strong agreement and very strong consensus  
Elements of ACP  
Extended definition: Advance care planning enables individuals who have decisional capacity to 
identify their values, to reflect upon the meanings and consequences of serious illness scenarios, to 
define goals and preferences for future medical treatment and care, and to discuss these with 
ĨĂŵŝůǇĂŶĚŚĞĂůƚŚĐĂƌĞƉƌŽǀŝĚĞƌƐ ?WĂĚĚƌĞƐƐĞƐŝŶĚŝǀŝĚƵĂůƐ ? concerns across the physical, 
psychological, social, and spiritual domains. It encourages individuals to identify a personal 
representative and to record and regularly review any preferences, so that their preferences can be 
taken into account should they at some point be unable to make their own decisions. 
 
Brief definition of ACP: Advance care planning enables individuals to define goals and preferences 
for future medical treatment and care, to discuss these goals and preferences with family and 
healthcare providers, and to record and review these preferences if appropriate. 
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ZĞĐŽŵŵĞŶĚĞĚĞůĞŵĞŶƚƐŽĨWĐŽŶĐĞƌŶƚŚĞĞǆƉůŽƌĂƚŝŽŶŽĨƚŚĞŝŶĚŝǀŝĚƵĂů ?ƐĐurrent understanding of 
WĂŶĚƚŚĞĂĚĂƉƚĂƚŝŽŶƚŽŽŶĞ ?ƐƌĞĂĚŝŶĞƐƐƚŽĞŶŐĂŐĞŝŶŝƚ ?&ƵƌƚŚĞƌŵŽƌĞ ?ŝƚŝƐƌĞĐŽŵŵĞŶĚĞĚƚŚĂƚW
ƐŚŽƵůĚŝŶĐůƵĚĞƚŚĞĞǆƉůŽƌĂƚŝŽŶŽĨƚŚĞŝŶĚŝǀŝĚƵĂů ?ƐƉĞƌƐŽŶĂůǀĂůƵĞƐĂŶĚŐŽĂůƐĨŽƌĨƵƚƵƌĞĐĂƌĞ ?tŚĞƌĞ
appropriate, ACP should include the provision of medical information (e.g. about diagnosis and 
prognosis) and the clarification of goals and preferences for future medical treatment and care 
(including an exploration of whether these are realistic). In addition, ACP should involve discussing 
the option of completing an advance care directive and of appointing a personal representative, 
along with determining their role, as per local legal jurisdiction. ACP should also encourage 
individuals to provide family and healthcare professionals with a copy of the advance care directive. 
 
Roles and tasks 
It is recommended that healthcare professionals tailor the ACP conversation to the individual's 
health literacy, style of communication, and personal values. Health care professionals need to have 
the necessary skills and display openness to discuss ACP and to provide individuals and their families 
with clear and coherent information. Furthermore, it is recommended that a trained non-physician 
facilitator can support an individual in the ACP process, and that the initiation of ACP can occur both 
in healthcare settings and non-healthcare settings. For medical elements of ACP (such as discussing 
diagnosis and exploring the extent to which goals and preferences for future medical treatment and 
care are realistic), healthcare providers are needed.  
 
Timing of ACP 
It is recommended that individuals can engage in ACP at any stage of their life, but that the ACP 
ĐŽŶƚĞŶƚĐĂŶďĞŵŽƌĞƚĂƌŐĞƚĞĚǁŚĞŶƚŚĞŝŶĚŝǀŝĚƵĂů ?ƐŚĞĂůƚŚĐŽŶĚŝƚŝŽŶǁŽƌƐĞŶƐŽƌĂƐĂŐĞŝŶŐ
progresses. In these circumstances, ACP conversations and documents should be updated regularly, 
as values and preferences may change over time. It is further recommended that public awareness 
of ACP should be raised.  
 
Elements of ACP policy and regulation 
It is recommended that advance care directives have both a structured (i.e. checkbox) and an open 
text format. Healthcare organisations are encouraged to develop triggers for the initiation of ACP, 
and set up reliable and secure systems to store copies of advance ĐĂƌĞĚŝƌĞĐƚŝǀĞƐŝŶƚŚĞƉĂƚŝĞŶƚ ?Ɛ
medical file. Governments, health insurers, and healthcare organisations are advised to secure 
appropriate funding and organisational support for ACP, and laws should recognise the results of an 
ACP process as legally binding guidance for medical decisions.  
 
Evaluation of ACP  
Depending on the study or project aims, we recommend a list of constructs to be assessed and high-
quality outcome measures to be identified or developed, so that results can be standardised, 
pooled, and compared.  
 
Recommendations that received strong agreement and (very) strong consensus  
For 36 of 41 recommendations, agreement was very strong. For five recommendations, agreement 
was strong (a median of 2). These five concern ACP which includes an exploration of the extent to 
which the individual allows their personal representative leeway in decision-making 
(Recommendation #8), the need for healthcare providers with regard to clinical elements of ACP 
(Recommendation #18), the format of the advance care directive (Recommendation #22), and two 
recommended constructs to be assessed, i.e. self-efficacy and healthcare utilisation 
(Recommendations #27B and #27M).  
 
Discussion 
For the first time, a unifying, transcultural, international consensus definition of ACP and 
recommendations for its application have been drafted through a rigorous, large international 
Delphi study. The recommendations guide the way in which ACP should be conducted and 
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integrated into healthcare, and suggest outcome measures of ACP. Most recommendations received 
full consensus from our multi-disciplinary panel, which also included patient representatives: the 
majority achieved this in one round, while others did so in subsequent rounds. This suggests that our 
recommendations are appropriate for a variety of healthcare settings, patient populations, and 
cultures. The high response rate from panellists implies that the issue is topical and of high relevance 
to clinical practice. We used hundreds of qualitative comments from panellists to improve the 
recommendations. The final definitions and recommendations provide important guidance for the 
delivery of high-quality ACP. We recommend their use in future studies and clinical programmes in 
order to facilitate the comparison and synthesis of findings across studies. 
 
Our international consensus study offers wider generalisability than earlier initiatives to define ACP 
and previously published guidelines or position papers, as these were limited to specific patient 
groups
6,8
 or to certain countries or cultures.
4-7,14
 The definitions and recommendations resulting 
from this study highlight how the focus of ACP is shifting from eliciting treatment instructions to be 
ƵƐĞĚǁŚĞŶĂŶŝŶĚŝǀŝĚƵĂů ?ƐĚĞĐŝƐŝŽŶĂůĐĂƉĂĐŝƚǇŚĂƐďĞĞŶůŽƐƚ ?ƚŽǁĂƌĚƐĐŽŵŵƵŶŝĐĂƚŝŽŶĂbout goals and 
preferences for future medical care across the age and illness spectrum.
18, 19
 Other important 
elements are that the scope of ACP is broader than the physical domain alone (and may include 
concerns across the psychological, social, and spiritual domains) and that ACP is not limited to 
specific patient groups (yet should concern individuals with decisional capacity). With this new focus, 
the concept of ACP has become increasingly relevant for many patient populations, such as those in 
the areas of oncology, chronic diseases, and multi-morbidity, and both for patients and healthcare 
providers. However, recent evidence suggests that in oncology, ACP tends to be limited to the 
completion of documents.
3
 
 
The definitions and recommendations reflect the value of ACP in providing care to people in 
different stages of their illness. Worldwide, the extent to which healthcare providers, patients, and 
relatives are willing and able to discuss issues related to disease progression and end-of-life care 
differs considerably, as does the extent to which such discussions are integrated into the healthcare 
system. Our recommendations therefore encourage an individualised approach to ACP, e.g. one that 
is tailored to whether or not people want to engage in ACP, to disease stage, and to local legal and 
cultural circumstances. Finally, the results reflect the reality that in many countries patients can 
express their preferences for care, but have different degrees of authority to refuse treatments and 
limited authority to request treatments themselves.  
 
This study has a number of strengths. First, the resulting recommendations owe their credibility to 
the rigorous use of the Delphi technique. We followed the reporting standard for Conducting and 
Reporting of Delphi Studies (CREDES).
20
 This included, for instance, the appointment of independent 
researchers to coordinate the study, the presence of a clear consensus criterion, clear descriptions 
of how the synthesis of responses in one survey round was used to design the subsequent round, 
and the review and approval of the final draft by an external board before publication and 
dissemination. Second, where possible, we built our definitions and recommendations on the 
available evidence about ACP by studying 90 published reviews about ACP and their respective 
references. Third, the Delphi methodology allowed the involvement of a network of 109 
geographically dispersed experts from 14 countries. These participants represented various 
professional backgrounds and work settings. In the expert panel, we also included nine patient 
representatives, an approach which is increasingly considered to add relevance to study results. Our 
response rate of 76% indicates that the risk of selection bias is fairly limited. Fourth, while Delphi 
studies aim to determine the extent to which experts agree about a construct (agreement) and the 
degree to which they agree with each other and resolve disagreements (consensus), firm rules 
regarding sufficient consensus and agreement levels are lacking. We used conservative cut-off levels 
(median of 1 indicating very strong agreement and an IQR of 0 or 1 indicating very strong 
consensus), adding robustness to our study outcomes. Fifth, the high degree of consensus and 
agreement among panel members contributes to the validity of our findings. Finally, the hundreds of 
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comments that were provided by panel members were systematically studied and used to improve 
the definitions and recommendations.  
 
We acknowledge the following limitations of our study. Systematic literature reviews were not 
feasible given the plenitude of scientific articles published on the topic of ACP with varying concepts, 
research questions, and methodology. In addition, the recommendations may need updating as 
more evidence becomes available. Furthermore, we acknowledge that both the evidence from the 
scientific literature and the expert views predominantly originate from resource-rich countries such 
as Europe, North America and Australia. There were no Asian, South American or African 
representatives. It is likely that cultural adaptations will be needed if definitions and 
recommendations are to be applied in regions that were not represented in the Delphi panel. In that 
case we recommend conducting an additional Delphi study. Lastly, our definitions and 
recommendations need validation in different populations. Whether the use of the 
recommendations will in fact improve processes or outcomes of care is a matter that warrants 
further study.  
 
As for future steps, we recommend the translation, dissemination, and implementation of these 
definitions and recommendations for use in practice and policymaking. We also recommend the 
evaluation of the recommendations ?ƵƐĞŝŶĐůŝŶŝĐĂůƉƌĂĐƚŝĐĞĂŶĚƉŽůŝĐǇ ?Future work may also include 
formal priority setting exercises of the recommendations.
21
 We are continuing our work to define 
ACP outcome domains and constructs.
4
 For instance, we are currently working in a separate Delphi 
study to develop a set of recommendations to standardize ACP constructs and instruments.
22, 23
 
Furthermore, we encourage the identification of measurement tools to assess the outcomes of ACP 
as recommended. Additionally, to enhance the wide applicability of our recommendations, we have 
aimed at providing general recommendations across disciplines. Future work may further specify the 
recommendations for specific disciplines, health care systems and local legal jurisdictions. We 
recommend that further attention be paid to ACP in the context of patients with limited capacity, as 
this was outside the scope of our work.  
 
Conclusion  
In conclusion, our large international Delphi panel was able to come to a consensus on an ACP 
definition and recommendations. This represents an important first step in providing clarity with a 
view to further policy and research in this field. We hope these recommendations will have a 
catalyst effect to further benefit patients and their relatives by facilitating the provision of care to 
oncology patients and others that is aligned to their preferences and goals, thus contributing to 
improved quality of life.  
 
Acknowledgements 
We thank all experts who participated in the Delphi study for their valuable input, and the EAPC 
Board members for their support in performing the Delphi study. We thank Bud Hammes for his 
ĂĚǀŝĐĞƚŚƌŽƵŐŚŽƵƚƚŚĞƉƌŽũĞĐƚ ?&ŝŶĂůůǇ ?ǁĞƚŚĂŶŬ ‘DĞƚĂŵŽƌĨŽƐĞsĞƌƚĂůŝŶŐĞŶ ?ĨŽƌƚŚĞŝƌůĂŶŐƵĂŐĞĂŶĚ
ŐƌĂŵŵĂƌĐŚĞĐŬ ?tĞƚŚĂŶŬ> ?KƌĠĂů-UNESCO for funding the For Women in Science Fellowship for 
JACR. 
 
Conflict of Interest Statement 
The authors declared no conflicts of interest.   
 
Contributions  
All authors (J Rietjens, R Sudore, M Connolly, J van Delden, M Drickamer, M Droger, A van der Heide, 
D Heyland, D Houttekier, D Janssens, L Orsi, S Payne, J Seymour, R Jox, I Korfage) have made 
substantial contributions to the conception (JR, RS, JvD, MDri, AvdH, DHo, DJ, LO, SP, JS, RJ, IK) and 
design (JR, RS, MC, JvD, MDri, AvdH, DHe, DHo, DJ, LO, SP, JS, RJ, IK) of the study, to the literature 
THIS IS A DRAFT COPY, FOR ORIGINAL PLEASE SEE RIETJENS ET AL, THE LANCET ONCOLOGY 2017, 18, No. 9, e543-e551 
http://dx.doi.org/10.1016/S1470-2045(17)30582-X   
10 
 
search (JR, IK), the data-collection (JR, IK, MDro), and to the draft and critical revision of the 
manuscript (JR, RS, MC, JvD, MDri, MDro, AvdH, DHe, DHo, DJ, LO, SP, JS, RJ, IK). All authors provided 
final approval of the final version and agree with submitting the final version to Lancet Oncology.
THIS IS A DRAFT COPY, FOR ORIGINAL PLEASE SEE RIETJENS ET AL, THE LANCET ONCOLOGY 2017, 18, No. 9, e543-e551 
http://dx.doi.org/10.1016/S1470-2045(17)30582-X   
11 
 
References  
1. Brinkman-Stoppelenburg A, Rietjens JA, van der Heide A. The effects of advance care 
planning on end-of-life care: a systematic review. Palliat Med 2014; 28(8): 1000-25. 
2. Houben CH, Spruit MA, Groenen MT, Wouters EF, Janssen DJ. Efficacy of advance care 
planning: a systematic review and meta-analysis. J Am Med Dir Assoc 2014; 15(7): 477-89. 
3. Johnson S, Butow P, Kerridge I, Tattersall M. Advance care planning for cancer patients: a 
systematic review of perceptions and experiences of patients, families, and healthcare providers. 
Psychooncology 2016; 25(4): 362-86. 
4. Sudore RL, Lum HD, You JJ, et al. Defining Advance Care Planning for Adults: A Consensus 
Definition from a Multidisciplinary Delphi Panel. Journal of Pain and Symptom Management 2017. 
5. Institute of Medicine . Committee on Approaching Death: Addressing Key End-of-Life I. Dying 
in America: Improving Quality and Honoring Individual Preferences Near the End of Life; 2015. 
6. Royal College of Physicians, Conroy S, Fade P, Fraser A, Schiff R, Guideline Development G. 
Advance care planning: concise evidence-based guidelines. Clinical Medicine 2009; 9(1): 76-9. 
7. National End of Life Care Programme (2011) Capacity, care planning and advance care 
planning in life limiting illness. Leicester: National End of Life Care Programme. 
8. Schrijvers D, Cherny NI, Group EGW. ESMO Clinical Practice Guidelines on palliative care: 
advanced care planning. Ann Oncol 2014; 25 Suppl 3: iii138-42. 
9. Billings JA, Bernacki R. Strategic targeting of advance care planning interventions: the 
Goldilocks phenomenon. JAMA internal medicine 2014; 174(4): 620-4. 
10. Barclay JS, Blackhall LJ, Tulsky JA. Communication strategies and cultural issues in the 
delivery of bad news. J Palliat Med 2007; 10(4): 958-77. 
11. De Vet E, Brug J, De Nooijer J, Dijkstra A, De Vries NK. Determinants of forward stage 
transitions: a Delphi study. Health Education Research 2005; 20(2): 195-205. 
12. Biondo PD, Nekolaichuk CL, Stiles C, Fainsinger R, Hagen NA. Applying the Delphi process to 
palliative care tool development: lessons learned. Supportive Care in Cancer 2008; 16(8): 935-42. 
13. Francke AL, Smit MC, de Veer AJE, Mistiaen P. Factors influencing the implementation of 
clinical guidelines for health care professionals: a systematic meta-review. BMC medical informatics 
and decision making 2008; 8(1): 38. 
14. Australian Medical Association. Position Statement on End of Life Care and Advance Care 
Planning 2014. https://ama.com.au/system/tdf/documents/AMA_position_statement_ 
on_end_of_life_care_and_advance_care_planning_2014.pdf?file=1&type=node&id=40573, 
accessed 07042017. 
15. Jones J, Hunter D. Consensus methods for medical and health services research. BMJ: British 
Medical Journal 1995; 311(7001): 376. 
16. Linstone HA, Turoff M. The Delphi method: Techniques and applications: Addison-Wesley 
Reading, MA; 1975. 
17. van der Steen JT, Radbruch L, Hertogh CMPM, et al. White paper defining optimal palliative 
care in older people with dementia: a Delphi study and recommendations from the European 
Association for Palliative Care. Palliative medicine 2014; 28(3): 197-209. 
18. Sabatino CP. The evolution of health care advance planning law and policy. Milbank Q 2010; 
88(2): 211-39. 
19. Seymour J, Horne G. Advance care planning for the end of life: An overview. In: Thomas K, 
Lobo B, eds. Advance Care Planning in End of Life Care. Oxford: Oxford University Press; 2011: 16-27. 
20. Jünger S, Payne SA, Brine J, Radbruch L, Brearley SG. Guidance on Conducting and REporting 
DElphi Studies (CREDES) in palliative care: Recommendations based on a methodological systematic 
review. Palliative Medicine 2017: 0269216317690685. 
21.  Johnson AP, Hanvey L, Baxter S, Heyland DK. Development of advance care planning 
research priorities: a call to action. Journal of palliative care. 2013;29(2):99. 
22. Howard M, Bonham AJ, Heyland DK, Sudore R, Fassbender K, Robinson CA, et al. Measuring 
engagement in advance care planning: a cross-sectional multicentre feasibility study. BMJ open. 
2016;6(6):e010375. 
THIS IS A DRAFT COPY, FOR ORIGINAL PLEASE SEE RIETJENS ET AL, THE LANCET ONCOLOGY 2017, 18, No. 9, e543-e551 
http://dx.doi.org/10.1016/S1470-2045(17)30582-X   
12 
 
23. Sudore RL, Heyland DK, Barnes DE, Howard M, Fassbender K, Robinson CA, et al. Measuring 
Advance Care Planning: Optimizing the Advance Care Planning Engagement Survey. Journal of pain 
and symptom management. 2017;53(4):669-81. e8. 
24. Parker SM, Clayton JM, Hancock K, et al. A systematic review of prognostic/end-of-life 
communication with adults in the advanced stages of a life-limiting illness: patient/caregiver 
preferences for the content, style, and timing of information. Journal of pain and symptom 
management 2007; 34(1): 81-93. 
25. Fried TR, Bullock K, Iannone L, O'Leary JR. Understanding advance care planning as a process 
of health behavior change. Journal of the American Geriatrics Society 2009; 57(9): 1547-55. 
26. Fried TR, Redding CA, Robbins ML, Paiva A, O'Leary JR, Iannone L. Stages of change for the 
component behaviors of advance care planning. Journal of the American Geriatrics Society 2010; 
58(12): 2329-36. 
27. Bernacki RE, Block SD, American College of Physicians High Value Care Task F. 
Communication about serious illness care goals: a review and synthesis of best practices. JAMA 
Intern Med 2014; 174(12): 1994-2003. 
28. Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, McIntyre L, Tulsky JA. Factors 
considered important at the end of life by patients, family, physicians, and other care providers. 
JAMA 2000; 284(19): 2476-82. 
29. Weiner JS, Cole SA. Three principles to improve clinician communication for advance care 
planning: overcoming emotional, cognitive, and skill barriers. J Palliat Med 2004; 7(6): 817-29. 
30. Mack JW, Weeks JC, Wright AA, Block SD, Prigerson HG. End-of-life discussions, goal 
attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent 
with preferences. Journal of Clinical Oncology 2010; 28(7): 1203-8. 
31. Baum EE. Advance care planning: beyond the living will. Cleveland Clinic journal of medicine 
2009; 76(5): 277. 
32. Silveira MJ, Kim SYH, Langa KM. Advance directives and outcomes of surrogate decision 
making before death. New England Journal of Medicine 2010; 362(13): 1211-8. 
33. Sehgal A, Galbraith A, Chesney M, Schoenfeld P, Charles G, Lo B. How strictly do dialysis 
patients want their advance directives followed? Jama 1992; 267(1): 59-63. 
34. Sulmasy DP, Hughes MT, Thompson RE, et al. How would terminally ill patients have others 
make decisions for them in the event of decisional incapacity? A longitudinal study. Journal of the 
American Geriatrics Society 2007; 55(12): 1981-8. 
35. Wendler D, Rid A. Systematic review: the effect on surrogates of making treatment decisions 
for others. Annals of Internal Medicine 2011; 154(5): 336-46. 
36. ^ƵĚŽƌĞZ> ?&ƌŝĞĚdZ ?ZĞĚĞĨŝŶŝŶŐƚŚĞ “ƉůĂŶŶŝŶŐ ?ŝŶĂĚǀĂŶĐĞĐĂƌĞƉůĂŶŶŝŶŐ PƉƌĞƉĂƌŝŶŐĨŽƌĞŶĚ-
of-life decision making. Annals of internal medicine 2010; 153(4): 256-61. 
37. Glaudemans JJ, Moll van Charante EP, Willems DL. Advance care planning in primary care, 
only for severely ill patients? A structured review. Fam Pract 2015; 32(1): 16-26. 
38. Teno JM, Gruneir A, Schwartz Z, Nanda A, Wetle T. Association between advance directives 
ĂŶĚƋƵĂůŝƚǇŽĨĞŶĚ ?ŽĨ ?ůŝĨĞĐĂƌĞ PŶĂƚŝŽŶĂůƐƚƵĚǇ ?Journal of the American Geriatrics Society 2007; 
55(2): 189-94. 
39. Hickman SE, Nelson CA, Moss AH, Tolle SW, Perrin NA, Hammes BJ. The Consistency 
Between Treatments Provided to Nursing Facility Residents and Orders on the Physician Orders for 
>ŝĨĞ ?^ƵƐƚĂŝŶŝŶŐdƌĞĂƚŵĞŶƚ&Žƌŵ ?Journal of the American Geriatrics Society 2011; 59(11): 2091-9. 
40. Clayton JM, Hancock K, Parker S, et al. Sustaining hope when communicating with terminally 
ill patients and their families: a systematic review. WƐǇĐŚŽͲKŶĐŽůŽŐǇ 2008; 17(7): 641-59. 
41. Sanders JJ, Robinson MT, Block SD. Factors Impacting Advance Care Planning among African 
Americans: Results of a Systematic Integrated Review. J Palliat Med 2016; 19(2): 202-27. 
42. Baker ME. Economic, political and ethnic influences on end-of-life decision-making: A decade 
in review. Journal of health & social policy 2002; 14(3): 27-39. 
43. Patel K, Janssen DJ, Curtis JR. Advance care planning in COPD. Respirology 2012; 17(1): 72-8. 
44. Bullock K. The influence of culture on end-of-life decision making. Journal of social work in 
end-of-life & palliative care 2011; 7(1): 83-98. 
THIS IS A DRAFT COPY, FOR ORIGINAL PLEASE SEE RIETJENS ET AL, THE LANCET ONCOLOGY 2017, 18, No. 9, e543-e551 
http://dx.doi.org/10.1016/S1470-2045(17)30582-X   
13 
 
45. Szmuilowicz E, El-Jawahri A, Chiappetta L, Kamdar M, Block S. Improving residents' end-of-
life communication skills with a short retreat: a randomized controlled trial. Journal of palliative 
medicine 2010; 13(4): 439-52. 
46. Fallowfield L, Jenkins V, Farewell V, Saul J, Duffy A, Eves R. Efficacy of a Cancer Research UK 
communication skills training model for oncologists: a randomised controlled trial. The Lancet 2002; 
359(9307): 650-6. 
47. Cavalieri TA, Latif W, Ciesielski J, Ciervo Jr CA, Forman LJ. How physicians approach advance 
care planning in patients with mild to moderate Alzheimer's disease. The Journal of the American 
Osteopathic Association 2002; 102(10): 541-4. 
48. Back AL, Arnold RM, Baile WF, et al. Efficacy of communication skills training for giving bad 
news and discussing transitions to palliative care. Archives of internal medicine 2007; 167(5): 453-60. 
49. Stewart F, Goddard C, Schiff R, Hall S. Advanced care planning in care homes for older 
people: a qualitative study of the views of care staff and families. Age and ageing 2011; 40(3): 330-5. 
50. Hickman SE, Keevern E, Hammes BJ. Use of the physician orders for life-sustaining treatment 
program in the clinical setting: a systematic review of the literature. J Am Geriatr Soc 2015; 63(2): 
341-50. 
51. Detering KM, Hancock AD, Reade MC, Silvester W. The impact of advance care planning on 
end of life care in elderly patients: randomised controlled trial. Bmj 2010; 340: c1345. 
52. Molloy DW, Guyatt GH, Russo R, et al. Systematic implementation of an advance directive 
program in nursing homes: a randomized controlled trial. Jama 2000; 283(11): 1437-44. 
53. Morrison RS, Chichin E, Carter J, Burack O, Lantz M, Meier DE. The effect of a social work 
intervention to enhance advance care planning documentation in the nursing home. Journal of the 
American Geriatrics Society 2005; 53(2): 290-4. 
54. Chan HYL, Pang S. Let me talk Wan advance care planning programme for frail nursing home 
residents. Journal of clinical nursing 2010; 19 ? ? ? ? ? ? ? P ? ? ? ?-84. 
55. <ŝƌĐŚŚŽĨĨ<d ?,ĂŵŵĞƐ: ?<ĞŚů< ?ƌŝŐŐƐ> ?ƌŽǁŶZ> ? ĨĨĞĐƚŽĨĂŝƐĞĂƐĞ ?^ƉĞĐŝĨŝĐĚǀĂŶĐĞ
ĂƌĞWůĂŶŶŝŶŐ/ŶƚĞƌǀĞŶƚŝŽŶŽŶŶĚ ?ŽĨ ?>ŝĨĞĂƌĞ ?Journal of the American Geriatrics Society 2012; 
60(5): 946-50. 
56. Song M-K, Kirchhoff KT, Douglas J, Ward S, Hammes B. A randomized, controlled trial to 
improve advance care planning among patients undergoing cardiac surgery. Medical care 2005; 
43(10): 1049-53. 
57. Litzelman DK, Inui TS, Griffin WJ, et al. Impact of Community Health Workers on Elderly 
Patients' Advance Care Planning and Health Care Utilization: Moving the Dial. Medical Care 2016. 
58. Austin CA, Mohottige D, Sudore RL, Smith AK, Hanson LC. Tools to Promote Shared Decision 
Making in Serious Illness: A Systematic Review. JAMA Intern Med 2015; 175(7): 1213-21. 
59. Jain A, Corriveau S, Quinn K, Gardhouse A, Vegas DB, You JJ. Video decision aids to assist 
with advance care planning: a systematic review and meta-analysis. BMJ Open 2015; 5(6): e007491. 
60. Robinson L, Dickinson C, Bamford C, Clark A, Hughes J, Exley C. A qualitative study: 
WƌŽĨĞƐƐŝŽŶĂůƐ ?ĞǆƉĞƌŝĞŶĐĞƐŽĨĂĚǀĂŶĐĞĐĂƌĞƉůĂŶŶŝŶŐŝŶĚĞŵĞŶƚŝĂĂŶĚƉĂůůŝĂƚŝǀĞĐĂƌĞ ? ‘ĂŐŽŽĚŝĚĞĂŝŶ
ƚŚĞŽƌǇďƵƚ Q ? ?Palliative medicine 2013; 27(5): 401-8. 
61. Auriemma CL, Nguyen CA, Bronheim R, et al. Stability of end-of-life preferences: a systematic 
review of the evidence. JAMA Intern Med 2014; 174(7): 1085-92. 
62. van der Steen JT, van Soest-Poortvliet MC, Hallie-Heierman M, et al. Factors associated with 
initiation of advance care planning in dementia: a systematic review. J Alzheimers Dis 2014; 40(3): 
743-57. 
63. Malcomson H, Bisbee S. Perspectives of healthy elders on advance care planning. Journal of 
the American Academy of Nurse Practitioners 2009; 21(1): 18-23. 
64. Janssen DJA, Spruit MA, Schols JMGA, et al. Predicting changes in preferences for life-
sustaining treatment among patients with advanced chronic organ failure. CHEST Journal 2012; 
141(5): 1251-9. 
65. Janssen DJA, Spruit MA, Schols JMGA, van der Sande FM, Frenken LA, Wouters EFM. Insight 
into advance care planning for patients on dialysis. Journal of pain and symptom management 2013; 
45(1): 104-13. 
THIS IS A DRAFT COPY, FOR ORIGINAL PLEASE SEE RIETJENS ET AL, THE LANCET ONCOLOGY 2017, 18, No. 9, e543-e551 
http://dx.doi.org/10.1016/S1470-2045(17)30582-X   
14 
 
66. Mullick A, Martin J, Sallnow L. An introduction to advance care planning in practice. Bmj 
2013; 347: f6064. 
67. Flo E, Husebo BS, Bruusgaard P, et al. A review of the implementation and research 
strategies of advance care planning in nursing homes. BMC Geriatr 2016; 16: 24. 
68. Kirkpatrick JN, Hauptman PJ, Goodlin SJ. Bundling informed consent and advance care 
planning in chronic cardiovascular disease: we need to talk. JAMA internal medicine 2015; 175(1): 5-
6. 
69. Dow LA, Matsuyama RK, Ramakrishnan V, et al. Paradoxes in advance care planning: the 
complex relationship of oncology patients, their physicians, and advance medical directives. Journal 
of Clinical Oncology 2010; 28(2): 299-304. 
70. Lamont EB, Siegler M. Paradoxes in cancer patients' advance care planning. Journal of 
palliative medicine 2000; 3(1): 27-35. 
71. Gott M, Gardiner C, Small N, et al. Barriers to advance care planning in chronic obstructive 
pulmonary disease. Palliative Medicine 2009; 23(7): 642-8. 
72. Wilson DM, Cohen J, Deliens L, Hewitt JA, Houttekier D. The preferred place of last days: 
results of a representative population-based public survey. Journal of palliative medicine 2013; 
16(5): 502-8. 
73. Yung VY, Walling AM, Min L, Wenger NS, Ganz DA. Documentation of advance care planning 
for community-dwelling elders. Journal of palliative medicine 2010; 13(7): 861-7. 
74. Skinner I, Smith C, Jaffray L. Realist review to inform development of the electronic advance 
care plan for the personally controlled electronic health record in australia. Telemed J E Health 2014; 
20(11): 1042-8. 
75. Johnson M, Attree M, Jones I, Al Gamal E, Garbutt D. Diagnosis, prognosis and awareness of 
dying in nursing homes: towards the Gold Standard? International journal of older people nursing 
2014; 9(2): 95-105. 
76. Ke LS, Huang X, O'Connor M, Lee S. Nurses' views regarding implementing advance care 
planning for older people: a systematic review and synthesis of qualitative studies. J Clin Nurs 2015; 
24(15-16): 2057-73. 
77. Bausewein C, Daveson BA, Currow DC, et al. EAPC White Paper on outcome measurement in 
palliative care: Improving practice, attaining outcomes and delivering quality services W
Recommendations from the European Association for Palliative Care (EAPC) Task Force on Outcome 
Measurement. Palliative medicine 2015: 0269216315589898. 
THIS IS A DRAFT COPY, FOR ORIGINAL PLEASE SEE RIETJENS ET AL, THE LANCET ONCOLOGY 2017, 18, No. 9, e543-e551 
http://dx.doi.org/10.1016/S1470-2045(17)30582-X   
15 
 
Appendix Characteristics of Delphi panelists (n= 109) 
  
Age 
 Mean (SD) 
 Age range  
 
50.3 (10.3) 
19-74 years 
Sex, n (%) 
 Female 
 
68 (62%) 
Country of residence, n (%)  
 UK  19 (17) 
 USA  14 (13) 
 The Netherlands 14 (13) 
 Australia 11 (10) 
 Germany 10 (9) 
 Italy 9 (8) 
 Spain  9 (8) 
 Ireland 8 (7) 
 Other
1
 15 (15) 
Expertise
2
, n (%)  
 Medicine
2,3
 51 (47) 
 Researcher
2,4
 52 (48) 
 Ethics, Philosophy and Law 26 (24) 
 Nursing 24 (22) 
 Psychology 12 (11) 
 Patient representative 9 (8) 
 Policy 8 (7) 
 Social worker 2 (2) 
 Teacher 2 (2) 
 Other
5
 1 (1) 
1.
Other: Belgium, Denmark, Canada, Slovenia, France, Portugal  
2.
 More than one option possible
   
  
3.
 Expertise included: Palliative medicine (n=32); Geriatrics (n=10); General practice (n=8); Critical 
care / intensive care medicine (n=6); Medical ethics (n=4); Internal medicine (n=3); Advanced illness 
medicine (n=2); Oncology (n=2); Psychiatry (n=2); Neurology (n=1); Pediatrics (n=1); Pulmonology 
(n=1); Legal medicine (n=1); Unknown (n=1). 
4.
 Researchers were specialized in Palliative care (n=25); Advance care planning (n=12); Ethics (n=7); 
Health communication (n=6); End of life decision making (n=5); Social science (n=4); Psycho-oncology 
(n=3); Ageing (n=2); Dementia (n=2); Law (n=2); Qualitative research (n=2); Quality of life (n=1); 
Death (n=1), Epidemiology (n=1); Outcomes (n=1); Policy (n=1); Frailty (n=1); Pain management 
(n=1); and/or Services (n=1). 
5. 
Other: ACP program coordinator 
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Table Final set of recommendations and ratings as provided by the panel (n=103) in Delphi round 3 
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Recommended elements of ACP     
1. dŚĞWƉƌŽĐĞƐƐŝŶĐůƵĚĞƐĂŶĞǆƉůŽƌĂƚŝŽŶŽĨƚŚĞŝŶĚŝǀŝĚƵĂů ?ƐƵŶĚĞƌƐƚĂŶĚŝŶŐŽĨWĂŶĚĂŶĞǆƉůĂŶĂƚŝŽŶŽĨŝƚƐĂŝŵƐ ?ĞůĞŵĞŶƚƐ ?ďĞnefits, 
limitations and legal status. 
91 1 1 53 
2. ACP should be adapted to the individual ?ƐƌĞĂĚŝŶĞƐƐƚŽĞŶŐĂŐĞŝŶƚŚĞWƉƌŽĐĞƐƐ3,10,24-26. 99 1 0 22 
3. WŝŶĐůƵĚĞƐƚŚĞĞǆƉůŽƌĂƚŝŽŶŽĨƚŚĞŝŶĚŝǀŝĚƵĂů ?ƐŚĞĂůƚŚ-related experiences, knowledge, concerns and personal values across the 
physical, psychological, social and spiritual domains 
27-29
. 
99 1 0 28 
4. ACP includes exploring goals for future care 
27
. 
100 1 0 34 
5. Where appropriate, ACP includes information about diagnosis, disease course, prognosis, advantages and disadvantages of possible 
treatment and care options 
9,30
. 
96 1 0 33 
6. ACP may include clarification of goals and preferences for future medical treatment and care. If appropriate, it includes exploration of 
the extent to which these goals and preferences are realistic 
27,30,31
. 
83 1 1 55 
7. ACP includes discussing the option and the role of the personal representative, who may act on behalf of the individual when they are 
unable to express their preferences, as per local legal jurisdiction 
32
. 
94 1 1 50 
8. ACP includes an exploration of the extent to which the individual allows their personal representative to take into consideration their 
current clinical context in addition to their prior stated preferences when expressing preferences on their behalf 
33-35
. 
74 2 2 31 
9. ACP may include the appointment of a personal representative and documentation thereof 
2,32,36
. 96 1 0 39 
10. ACP includes information about the option and role of an advance care directive (which is a document to record values, goals and 
preferences to be considered when he or she is unable to express their preferences) as per local legal jurisdiction 
32
. 
95 1 0 37 
11. ACP may include the completion of an advance care directive 
2,32,37-39
. 94 1 0 25 
12. ACP includes encouraging an individual to provide family and healthcare professionals with a copy of the advance care directive.  82 1 1 23 
     
Recommended roles and tasks     
13. Healthcare professionals should adopt a person-centered approach when engaging in ACP conversations with individuals and, if the 
individual prefers so, their family. This requires tailoring the ACP conversation to the individual's health literacy, style of 
communication, and personal values 
24,25,40-44
. 
100 1 0 25 
14. Healthcare professionals need to have the necessary skills and display an openness to talk about diagnosis, prognosis, death and dying 
with individuals and their family 
6,27,40,43,45-48
.   
99 1 0 34 
15. Healthcare professionals should provide individuals and their family with clear and coherent information concerning ACP 
49
. 99 1 0 21 
16. A trained non-physician facilitator can support an individual in the ACP process 
1, 50-57
.   91 1 0 46 
17. dŚĞŝŶŝƚŝĂƚŝŽŶŽĨW ?ƚŚĂƚŝƐ ?ƚŚĞĞǆƉůŽƌĂƚŝŽŶŽĨƚŚĞŝŶĚŝǀŝĚƵĂů ?ƐĞǆƉĞƌŝĞŶĐĞƐ ?ŬŶŽǁůĞĚŐĞ ?ƉĞƌƐŽŶĂůǀĂůƵĞƐ ?ĂŶĚĐŽŶĐĞƌŶƐ ?ĐĂn occur in 
healthcare settings or non-healthcare settings 
58,59
. 
98 1 0 31 
18. Appropriate healthcare providers are needed for clinical elements of ACP, such as discussing diagnosis, prognosis, treatment and care 
options, exploring the extent to which goals and preferences for future medical treatment and care are realistic and documenting the 
68 2 2 39 
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discussion in the medical file 
60
. 
     
Recommended timing of ACP      
19. Individuals can engage in ACP in any stage of their life, but its content can be more targeted as their health condition worsens or as 
they age 
9,61-63
. 
 
 
96 1 0 39 
20. As values and preferences may change over time, ACP conversations and documents should be updated regularly, e.g. as the 
ŝŶĚŝǀŝĚƵĂů ?ƐŚĞĂůƚŚĐŽŶĚŝƚŝŽŶǁŽƌƐĞŶƐ ?ƚŚĞŝƌƉĞƌƐŽŶĂůƐŝƚƵĂƚŝŽŶĐŚĂŶŐĞƐ ?ŽƌĂƐƚŚĞǇĂŐĞ24,27,61,64-66. 99 1 0 18 
21. Public awareness of ACP should be raised. This concerns the aims and content of ACP, as well as its legal status and how to access it. 96 1 0 17 
 
 
    
Recommended elements of policy and regulation     
22. Advance care directives need both a structured format to enable easy identification of specific goals and preferences in emergency 
situations, and an open text format so individuals can describe their values, goals, and preferences 
60, 67
. 
80 2 1 57 
23. Healthcare organizations should develop potential triggers for the initiation of ACP including but not limited to age, degree of illness, 
and transitions in care 
9,27,66,68-71
. 
95 1 0 31 
24. Healthcare organizations need to create reliable and secure systems to store copies of advance care directives in the medical file so 
that these are easy to retrieve, transfer, and update 
27,72-74
. 
97 1 0 29 
25. Governments, health insurers and healthcare organizations should secure appropriate funding and organizational support for ACP 
67,75,76
. 
100 1 0 20 
26. Laws should recognize results of an ACP process (such as surrogate decision making and advance care directives) as legally binding 
guidance of medical decision making. 
91 1 0 37 
     
Recommended evaluation of ACP     
27. Depending on the study- or project aims, we recommend the following constructs be assessed:     
A. Knowledge of ACP (rated by individuals, family, and healthcare professionals)  91 1 1  
B. Self-efficacy to engage in ACP (rated by individuals, family, and healthcare professionals) 84 2 1  
C. Readiness to engage in ACP (rated by individuals, family, and healthcare professionals) 92 1 1  
D. Identification of goals and preferences 96 1 0  
E. Communication about goals and preferences with family 96 1 1  
F. Communication about goals and preferences with healthcare professionals 98 1 1  
G. Identification of a personal representative 92 1 1  
H. Documentation of goals and preferences 95 1 0  
I. Revision of ACP discussions and documents over time 96 1 0  
J. Extent to which ACP was considered meaningful and helpful (rated by individuals, family, and healthcare professionals) 96 1 0  
K. Quality of ACP conversations (rated by individuals, family, facilitators and/or healthcare professionals) 90 1 1  
L. Satisfaction with the ACP process (rated by individuals, family, and healthcare professionals) 94 1 1  
M. Healthcare utilization 83 2 1  
N. WhetŚĞƌĐĂƌĞƌĞĐĞŝǀĞĚǁĂƐĐŽŶƐŝƐƚĞŶƚǁŝƚŚƚŚĞŝŶĚŝǀŝĚƵĂů ?ƐĞǆƉƌĞƐƐĞĚŐŽĂůƐĂŶĚƉƌĞĨĞƌĞŶĐĞƐ 92 1 0  
28. We recommend identifying or developing outcome measures regarding the aforementioned constructs so results can be pooled and 
compared across studies or projects. These outcome measures should have sound psychometric properties, be sufficiently brief, and 
validated within relevant populations 
77
. 
89 1 1 37 
 
1 ^ƵŵŽĨ>ŝŬĞƌƚƌĞƐƉŽŶƐĞŽƉƚŝŽŶƐ ‘ŐƌĞĞƐƚƌŽŶŐůǇ ?ĂŶĚ ‘ŐƌĞĞ ? 
